21 Oct 2025

"Blackstone and TPG Reach $18.3 Billion Agreement to Acquire Hologic, Inc."

"Kirkland & Ellis has advised Blackstone and TPG on a definitive agreement to acquire Hologic, Inc. for up to $18.3 billion. The deal involves purchasing Hologic shares at $76 each, with potential additional payments based on revenue goals for Hologic's Breast Health business. The transaction is expected to close in the first half of 2026, pending stockholder and regulatory approvals. The Hologic Board has unanimously approved the merger and recommends stockholders vote in favor."

Kirkland & Ellis advised Blackstone and TPG in their definitive agreement to acquire Hologic, Inc. for an enterprise value of up to $18.3 billion. Under the terms of the agreement, Blackstone and TPG will purchase all outstanding shares of Hologic at a price of $76 per share in cash, along with a non-tradable contingent value right (CVR) that could yield up to an additional $3 per share, contingent upon achieving specific revenue goals for Hologic’s Breast Health business in fiscal years 2026 and 2027. The transaction is anticipated to close in the first half of calendar year 2026, pending approval from Hologic’s stockholders and necessary regulatory approvals. The Kirkland team involved in this transaction included corporate lawyers Lauren Colasacco, Chris Burwell, and Daniel Yip; debt finance lawyers Melissa Hutson, Yuli Wang, Tim Hughes, and Scott Rolnik; tax lawyers Mike Beinus and Vivek Ratnam; and executive compensation lawyers Mike Krasnovsky, Matt Wood, and Jenny Cha.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.